UK children with a rare and aggressive brain cancer have been locked out of a potentially life-extending drug trial due to Brexit.
Around 30 children in Britain each year are diagnosed with Diffuse Intrinsic Pontine Glioma (DIPG) – an incurable and inoperable tumour that affects the brainstem, which controls vital functions such as breathing, swallowing, and facial expressions.